메뉴 건너뛰기




Volumn 24, Issue 5-6, 2001, Pages 983-992

HPLC and GC-MS screening of Chinese proprietary medicine for undeclared therapeutic substances

Author keywords

Chinese medicine; Codeine; Gas chromatographic mass spectrometry; High performance liquid chromatography; Reversed phase chromatography

Indexed keywords

ACETAZOLAMIDE; AMILORIDE; AMINOPHYLLINE; AMODIAQUINE; ANTIASTHMATIC AGENT; ANTIBIOTIC AGENT; CAFFEINE; CHINESE DRUG; CIMETIDINE; CODEINE; CORTICOSTEROID; DIAZEPAM; DICLOFENAC; DIGITOXIN; ESTRADIOL; FLUCYTOSINE; FUROSEMIDE; INDOMETACIN; MINOXIDIL; NALIDIXIC ACID; NALOXONE; NEOSTIGMINE; NONSTEROID ANTIINFLAMMATORY AGENT; NYSTATIN; OXAZEPAM; PARACETAMOL; PHENACETIN; PHENAZONE; RANITIDINE; UNINDEXED DRUG;

EID: 0035090005     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(00)00571-9     Document Type: Conference Paper
Times cited : (60)

References (31)
  • 30
    • 0005661445 scopus 로고    scopus 로고
    • The Statutes of the Republic of Singapore, Medicines Act (Chapter 176). The Government Printer, Ministry of Health, Singapore


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.